Tha authors analyzed RNA sequencing data to investigate the comprehensive transcriptomic landscape of Verteporfin treated Type 1 endometrial cancer cell lines, including HEC-1-A and HEC-1-B.
Full description or abstract
Verteporfin is a porphyrinic photosensitizer clinically used for the photodynamic treatment of age-related macular degeneration. The authors previously tested the efficacy of Verteporfin in endometrial cancer cells and observed cytotoxic and anti-proliferative effects.
Collection
M2: Curated CGP: Chemical and Genetic Perturbations